2021 Korean Society of Gastrointestinal Endoscopy Clinical Practice Guidelines for Endoscopic Sedation.

Sedation can resolve anxiety and fear in patients undergoing endoscopy. The use of sedatives has increased in Korea. Appropriate sedation is a state in which the patient feels subjectively comfortable while maintaining the airway reflex for stable spontaneous breathing. The patient should maintain a state of consciousness to the extent that he or she can cooperate with the needs of the medical staff. Despite its benefits, endoscopic sedation has been associated with cardiopulmonary complications. Such cardiopulmonary complications are usually temporary, and most patients recover without sequelae. However, these events may progress to serious complications, such as cardiovascular collapse. Therefore, it is essential to screen high-risk patients before sedation and reduce complications by meticulous monitoring. Additionally, physicians should be familiar with the management of emergencies. The first Korean clinical practice guideline for endoscopic sedation was developed based on previous worldwide guidelines for endoscopic sedation using an adaptation process. The guideline consists of nine recommendations based on a critical review of currently available data and expert consensus when the guideline was drafted. These guidelines should provide clinicians, nurses, medical school students, and policy makers with information on how to perform endoscopic sedation with minimal risk.

INTRODUCTION

1. Background

Endoscopic sedation is performed to reduce the patient’s anxiety during the procedure. Due to the high satisfaction with sedation among both endoscopists and patients, the use of endoscopic sedation is on the rise. Although most sedation cases are performed without safety issues, the use of sedatives can result in adverse events (AEs) in some cases. Therefore, clinical practice guidelines (CPGs) for endoscopic sedation, delineating measures for early detection of potential AEs of sedation and prevention of AEs before they progress to fatal stages are needed through active monitoring and emergency response. As each country has unique healthcare settings, CPGs for endoscopic sedation tailored to each country have been published. However, there are no CPGs for endoscopic sedation in Korea so far. Amid the dire need for CPGs tailored to the Korean society, the Korean Society of Gastrointestinal Endoscopy (KSGE) has collaborated with other relevant academic societies to develop multidisciplinary CPGs.

2. Target population, scope, purpose, and users of CPGs

The present CPGs target all adult males and females who undergo endoscopic sedation. These guidelines contain essential information to evaluate patients and prepare for sedation before endoscopic sedation, monitor patients and oxygenation during sedation, and prepare for discharge after sedation to avoid potential cardiopulmonary complications. In particular, these guidelines focus primarily on moderate sedation, the most widely used type of sedation for endoscopy. The scope of these CPGs was determined by the CPG development group by identifying key questions following the Patient Intervention Comparison Outcomes strategy. The users of these CPGs are all physicians who practice endoscopy and their assistant nursing staff when performing an endoscopic sedation procedure in clinical practice. Furthermore, these guidelines can also be used by medical students, nursing students, residents, and fellows who are in training, and nurses for educational purposes. These guidelines can also be used as a reference for the quality assessment of endoscopy units.

3. Composition of the CPGs committee and multidisciplinary involvement

The committee for the development of these CPGs comprised a Steering Committee (consisting of board members of the KSGE) and a Development Committee (consisting of members of the Endoscopic Sedation Committee of the KSGE, methodology specialists for guidelines, and advisory members from other relevant academic societies). The Steering Committee established strategies and directions for guideline development, appointed a chairperson of the committee, and reviewed and approved the budget. The Steering Committee also mediated between stakeholders regarding guideline development and supervised to ensure independence in editing. The Development Committee was headed by the director of the Endoscopic Sedation Committee of KSGE (Byung-Wook Kim). The assistant administrator (Hong Jun Park) and members of the Endoscopic Sedation Committee of KSGE (Jun Kyu Lee, Yehyun Park, Jin Myung Park, Jun Yong Bae, Seung Young Seo, Jae Min Lee, Jee Hyun Lee, Hyung Ku Chon, Jun-Won Chung, and Hyun Ho Choi) authored the manuscript for each key question. It has been decided that these CPGs will be developed by adapting existing guidelines. Therefore, a researcher from the National Evidence-based Healthcare Collaborating Agency (NECA; Dong Ah Park) and an expert from the Center of Evidence Based Medicine Institute of Convergence Science, Yonsei University (Jae Hung Jung), were recruited. A librarian from the medical library at Yonsei University School of Medicine at Wonju (Myung Ha Kim) was also recruited to assist in the literature search. Since 2019, a total of nine rounds of workshops for CPGs for endoscopic sedation were held with board members of the Korea Medical Association, the Korean Society of Anesthesiologists, the Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy Nurses and Associates, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association for the Study of Intestinal Diseases, and Korean Pancreatobiliary Association participating as advisors. The Development Committee evaluated the process with the assistance of a methodology expert. A consensus was reached on the finalized key questions among representatives of the organizations that participated in the development of the CPGs. A conference call was held with the experts.

4. Internal review, external review, and advice on the draft CPGs

Recommendations were first drafted by the Development Committee and reviewed internally. The statements were then sent to each participating organization by e-mail to obtain consent. At the 64th KSGE seminar on August 22, 2021, an online conference call was held with about 300 members to reach a consensus among experts. Feedback was presented during the review process and matters decided by vote were collated to be reviewed and revised. For objective verification, the CPGs were reviewed by two gastroenterologists (Jeong-Sik Byeon, Ulsan University College of Medicine and Hye-Kyung Jung, Ewha Womans University) who did not participate in CPG development. These CPGs were then discussed and revised by the Development Committee after peer review.

5. CPGs publication and dissemination

CPGs will be available through the KSGE (http://www.gie.or.kr) and the Korean Association of Internal Medicine (KAIM) websites (http://www.kaim.or.kr). The Korean version will be published in the Korean Journal of Gastroenterology, and the English version will be published through Clinical Endoscopy, an official journal of KSGE, along with Gut and Liver, an international journal. In addition, the draft CPGs will be published in A Guidebook on Endoscopic Sedation 2021 revised edition.

6. Update of CPGs

These CPGs are planned to be updated every 5 years after completion if clinical evidence for safer endoscopic sedation is accumulated or if it is deemed necessary to add a new statement and revise and supplement an existing statement. KSGE primarily undertakes the update process. These CPGs were developed in reference to CPGs published in or before May 2021 and in reference to each item in or before September 2019.

7. Conflict of interest in guideline developers

Before beginning guideline development, all members were required to sign a document declaring no conflict of interest, such as advising or being employed by a commercially linked organization during the CPG development or approval process, owning commercial shares or receiving research funds or compensation from such organizations, owning intellectual property rights for drugs specified in the guideline development (e.g., patent, trademark rights, licensing, and royalty), and having a family member or family member’s affiliation with the above-described relationship. All members declared no conflict of interest.

METHOD OF DEVELOPING CPGS FOR ENDOSCOPIC SEDATION

Recently published international CPGs for sedation are well organized. They also contain similar content. Therefore, an adaptation method was used to develop CPGs for endoscopic sedation relevant to the Korean environment.

1. Identification of key questions

The members of the Development Committee began to identify key questions for endoscopic sedation through nine workshops since 2019. Twenty-two key questions (10 items for pre-sedation, 8 items for intra-sedation, and 4 items for post-sedation) were initially developed. These questions were further reviewed and discussed for redundancy, a reflection of the endoscopic sedation environment in Korea, and effective prevention of fatal AEs. As a result, a total of 10 items (4 items for pre-sedation, 4 items for intra-sedation, and 2 items for post-sedation) were selected. These initially proposed 22 key questions are delineated in Supplementary Table 1, and the selected 10 items are delineated in Supplementary Table 2.

2. Literature search and quality appraisal

The international CPGs that would serve as the foundation of the Korean CPGs were searched by a librarian in the medical library of Yonsei University School of Medicine in Wonju, Korea. A literature search was conducted in Ovid-MEDLINE, EMBASE, KoreaMed, and KMbase using the MeSH terms “sedation” and “guideline,” with the end date set for September 2019. Searches were also conducted on the CPGs websites, namely the Guidelines International Network, National Institute of Health and Care Excellence, World Health Organization, and Korean Medical Guideline Information Center. In total, 946 articles were identified. The following criteria were used for literature selection: (1) evidence-based CPGs; (2) national or international CPGs; (3) (latest) CPGs published in 2010 or later; (4) externally reviewed CPGs; (5) CPGs published in English or Korean; and (6) CPGs published in adjacent countries. CPGs written by a single author that lacked representativeness and CPGs published without reference were excluded (Fig. 1, Supplementary Table 3). The initially selected guidelines included the 2010 European Society of Gastrointestinal Endoscopy (ESGE) CPGs, 2014 Spanish Society of Digestive Endoscopy CPGs, 2015 ESGE CPGs-updated, 2015 Japan Gastroenterological Endoscopy Society (JGES) CPGs, and American Society for Gastrointestinal Endoscopy (ASGE) 2018 CPGs. An updated version of the 2010 ESGE CPGs was published in 2015. Therefore, the latest version was chosen for these Korean CPGs. The 2014 Spanish Society of Digestive Endoscopy CPGs was excluded due to the lack of an English version. During the development of the Korean CPGs, an update of the JGES CPGs was published in 2020. Thus, the 2020 version was chosen for the JGES CPGs. These selected international CPGs were assessed by four members using the Appraisal of Guidelines for Research and Evaluation (AGREE) 2.0 tool. Three CPGs (2015 ESGE CPGs, 2018 ASGE CPGs, and 2020 JGES CPGs) with an average score of 50% or higher were selected. During the development period, the revised JGES CPGs were published in 2020, and this revised version was assessed using the same method. The revised 2020 version of the JGES CPGs was selected instead of the 2015 version of the JGES CPGs.

Fig. 1

Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) flowchart for selecting reference clinical practice guidelines.

NICE, National Institute of Health and Care Excellence; WHO, World Health Organization; KMbase, Korean Medical Database; KoMGI, Korean Medical Guideline Information Center.

3. Assessment of recency

The ESGE guidelines, ASGE guidelines, and JGES guidelines included references published up to February 2015, August 2017, and June 2019, respectively. Thus, a recency assessment was performed to add the latest references up to May 2020 for each key question.

4. Determination of the level of evidence and grade of recommendation

In general, the recommendation grade is commensurate with the level of evidence. However, in the absence of relevant literature, expert opinions were added to the level of evidence. A relatively high grade of recommendation was assigned to practices with weakly supported evidence if the practice was highly useful in clinical practice. Table 1 presents the level of evidence. Table 2 shows the grades of recommendations determined through several rounds of discussion.

Table 1

Level of Evidence

Level of evidence
A	Definition	There is clear evidence supporting the recommendation
	Example	One or more RCT, meta-analysis, or systematic review
B	Definition	There is reliable evidence supporting the recommendation
	Example	One or more well-performed non-RCT such as patient-controlled study or cohort study
C	Definition	There is evidence to support the recommendation, but it is unreliable
	Example	Low level of relevant evidence, such as observational studies and case reports
D	Definition	The evidence for the recommendation is expert opinion based on clinical experience and expertise

RCT, randomized controlled trial.

Table 2

Grade of Recommendation

Grade of recommendation
I	Definition	Recommendation is supported by clear evidence and benefits and is highly useful in clinical practice
	Expression	Strongly recommend
II	Definition	Recommendation is supported by reliable evidence and benefits and is highly or moderately useful in clinical practice
	Expression	Recommend
III	Definition	Level of evidence and benefits are unreliable, but the practice is highly or moderately useful in clinical practice
	Expression	Suggest
IV	Definition	Level of evidence is not reliable, and the practice may result in harmful outcomes and have low utility in clinical practice
	Expression	Do not recommend

5. Expert consensus and external review

After finalizing the draft, a conference call was held with about 300 experts at the 64th KSGE seminar on August 22, 2021. A 5-point rating scale composed of “strongly agree,” “agree,” “neither,” “disagree,” and “strongly disagree” was used, and the consensus was considered reached when “strongly agree” and “agree” exceeded 2/3 of the responses. Of the 10 final items, nine items were passed with a passing vote of 2/3 or greater. However, key question 8 (Is continuous electrocardiogram monitoring necessary for high-risk patients undergoing endoscopic sedation? Statement: We suggest continuous electrocardiogram monitoring during endoscopic sedation to prevent fatal AEs in significantly high-risk patients (e.g., cardiovascular disease, arrhythmia, pulmonary disease, old age, requiring extended procedure [Evidence level C, Grade of recommendation III]) was removed as only 64.6% of experts agreed (Supplementary Table 2). The final statements are summarized in Table 3.

Table 3

Summary of the Statements, Grade of Recommendation, and Level of Evidence

Statement	Grade of recommendation	Level of evidence
1. We recommend that physicians who administer endoscopic sedation and their assistant healthcare staff receive BLS training to prevent fatal progression of sedation AEs, such as death.	II	D
2. We recommend equipping the endoscopy unit with equipment and drugs for emergency resuscitation, as fatal AEs, such as drug-related dyspnea, hypotension, and shock, may occur during endoscopic sedation.	II	C
3. We recommend assessing the patients’ age, history, BMI, Mallampati score, and ASA Physical Status class to prevent AEs related to sedation.	II	B
4. We recommend reducing the initial and additional doses to reduce the incidence of severe AEs of endoscopic sedation in older adults.	II	C
5. We suggest that properly trained personnel in addition to the endoscopist monitor sedation during endoscopic sedation to prevent fatal AEs during highly challenging endoscopic procedures or extended procedures.	III	D
6. We strongly recommend supplemental oxygen administration before and during endoscopic sedation to prevent severe hypoxia.	I	A
7. We strongly recommend continuously assessing the level of consciousness, performing pulse oximetry, and performing noninvasive blood pressure monitoring during endoscopic sedation to enable early detection and treatment of sedation-related AEs.	I	B
8. We suggest that appropriate criteria should be established to determine a patient’s readiness for discharge to ensure safe recovery and that the level of consciousness, appendicular skeletal muscle activity, respiration, circulation, and oxygen saturation should be considered as criteria for discharge.	III	D
9. We recommend that patients who undergo endoscopic sedation be accompanied by a caregiver to assist with safe discharge, as psychomotor and cognitive impairments can occur after sedation.	II	C

BLS, basic life support; AEs, adverse events; BMI, body mass index; ASA, American Society of Anesthesiologists.

We recommend that physicians who administer endoscopic sedation and their assistant healthcare staff receive BLS training to prevent fatal progression of sedation AEs, such as death. (Evidence level: D, Grade of recommendation: II, Expert consensus: 88.0%)

KEY QUESTIONS FOR THE EVALUATION OF PATIENTS BEFORE SEDATION AND PREPARATION OF SEDATION

Question 1. Is having at least one healthcare provider involved in sedation receiving basic life support (BLS) training effective in responding to the patient’s AEs?

Background: Proper knowledge about sedation and fostering emergency response competencies through life support training are essential to ensure safe endoscopic sedation and timely response to sedation-related AEs. Life support training programs include BLS, advanced cardiac life support, and Korean advanced life support. BLS comprises the initial steps in cardiopulmonary resuscitation, such as cardiac arrest confirmation, opening of the airway, artificial respiration, and chest compression. Advanced cardiac life support comprises basic cardiopulmonary resuscitation, electrical defibrillation, airway control, breathing support, and assessment. Diverse curricula are used by different countries and agencies to train physicians who administer endoscopic sedation. The need for education has been proposed by several clinical recommendations.1-3 Furthermore, training healthcare providers involved in endoscopic sedation, including nurses, about emergency situations was effective in improving patient safety and the environment of the procedure.4 Although prospective comparative studies on the effects of life support training have not been conducted, physicians and healthcare providers are recommended to undergo relevant training from a safety perspective, such as managing side effects and AEs.

We recommend equipping the endoscopy unit with equipment and drugs for emergency resuscitation, as fatal AEs, such as drug-related dyspnea, hypotension, and shock, may occur during endoscopic sedation. (Evidence level: C, Grade of recommendation: II, Expert consensus: 94.4%)

Question 2. Can equipping the endoscopy unit with equipment and drugs for emergency resuscitation reduce fatal sedation-related AEs in patients undergoing endoscopic sedation?

Background: Most adverse drug reactions of sedatives used during endoscopic sedation are mild and temporary. However, life-threatening events, such as hypoxia, arrhythmia, and anaphylactic reactions, can occur in rare cases.5,6 A prospective multicenter study involving 191,142 participants reported that sedation-related AEs occurred in 82 (0.00042%) patients, six (0.00003%) of whom died from respiratory failure, hypotension, or cardiac arrest.7 A prospective study of 1,016 patients also observed cases of hypoxia (n=74, 7.3%), hypotension requiring pressor agents (n=8, 0.8%), and premature termination of the procedure (n=6, 0.6%) after sedative administration, with 141 (13.8%) patients requiring airway control.8 In addition, one study reported that cardiovascular AEs that required atropine or antagonistic agents occurred during endoscopic sedation in approximately 2.7% of cases.9

The ASGE, ESGE, and JGES CPGs recommend equipping the endoscopy unit with drugs and equipment needed for emergency resuscitation, along with periodic patient monitoring during endoscopic sedation. Korean Accredited Endoscopy Unit Certification Guidelines also recommend that endoscopy units should be equipped with emergency resuscitation devices (e.g., laryngeal masks or tracheal intubation equipment and defibrillators) and emergency medications (e.g., epinephrine, flumazenil, and naloxone) to be able to deal with emergency situations during endoscopic sedation. However, due to ethical and practical limitations in study design, currently there are no studies presenting data to conclude whether equipping the unit with drugs and equipment for emergency response can reduce the incidence of fatal sedation-related AEs. However, considering that most cases of sedative-associated deaths were induced by hypoxia and airway obstruction, as previously mentioned, it is necessary to equip the unit with appropriate emergency resuscitation equipment and drugs. Such readiness would allow healthcare providers to appropriately deal with abnormalities, such as abnormal vital signs, to reduce the incidence of fatal sedation-related AEs.

We recommend assessing the patients’ age, history, BMI, Mallampati score, and ASA Physical Status class to prevent AEs related to sedation. (Evidence level: B, Grade of recommendation: II, Expert consensus: 79.2%)

Question 3. Is assessing patients’ age, history, body mass index (BMI), Mallampati score, and American Society of Anesthesiologist (ASA) Physical Status class effective in preventing AEs of endoscopic sedation?

Background: Sedation alleviates the patient’s anxiety, discomfort, and pain during endoscopy and minimizes the unpleasant memory of discomfort or pain experienced during the procedure. Moreover, it ensures an environment where the endoscopist can concentrate on the procedure, thus facilitating a smooth procedure. However, as sedation can induce side effects, necessary measures should be taken to prevent them. Understanding the patient preprocedurally is part of such an effort.

Patients’ age, history, BMI, Mallampati classification, and ASA Physical Status class were associated with AEs of endoscopic sedation in multiple studies. Although the level of evidence is not high due to the lack of randomized controlled trials (RCTs), such pre-sedation assessment is beneficial in that it is easy for the patient. Thus, several CPGs consistently recommend such assessments.2,10,11

Sedation-related AEs are more common in older patients. This was observed with various sedatives and endoscopic examinations.12-14 Therefore, sedatives should be used with caution in older patients. However, there is no widely accepted standard for “old age,” and the ASGE CPGs did not present a clear-cut definition of the elderly either.11

A history assessment involves checking various factors that may influence sedation, including sleep apnea, drug allergy, current medications used, history of sedation-related and anesthesia-related AEs, time of last oral feeding and type of food consumed, alcohol consumption, smoking, substance abuse, pregnancy, and breastfeeding status.2,15 Cardiovascular diseases, kidney diseases, and liver diseases are also known risk factors for sedation-related AEs. Therefore, they must be checked.16 BMI is an independent risk factor for sedation-related AEs. Many studies have confirmed that the incidence of AEs increases with increasing BMI.10 No CPGs clearly define a high BMI. However, it is generally accepted that a BMI over 25 kg/m2 is considered a high-risk factor for hypoxia.14

The Mallampati classification (Fig. 2) helps identify patients with potential sleep apnea and predicts challenging endotracheal intubation.17 The ESGE CPGs recommend the primary involvement of an anesthesiologist for patients with a Mallampati class of 3 or higher.10 Furthermore, the incidence of AEs increases with high ASA Physical Status classes (Table 4).18,19 Based on these, several CPGs recommend that endoscopists to consult an anesthesiologist.2,10,11 However, the specific cutoff for anesthesiologist involvement varies across guidelines (class 3 or 4), making it practically difficult to adhere to such recommendations in the Korean clinical setting. Therefore, endoscopists should take more precautions when performing endoscopic sedation in these patients. The decision to consult an anesthesiologist should consider various factors, including the targeted depth of sedation, patient’s state, and circumstances of the healthcare facility.

Fig. 2

Mallampati classification of airways. The patient is assessed while sitting up with the mouth opened wide and tongue protruded as much as possible.

Table 4

American Society of Anesthesiologists Physical Status Classification (https://www.asahq.org/standards-and-guidelines/asa-physical-status-classification-system)

Patient’s status
Class I	Normal health without systemic disease
Class II	Mild systemic disease
Class III	Severe systemic disease
Class IV	Severe life-threatening systemic disease
Class V	Moribund, not expected to survive without surgery
Class VI	Declared brain-dead, undergoing surgery for organ donation purposes

We recommend reducing the initial and additional doses to reduce the incidence of severe AEs of endoscopic sedation in older adults. (Evidence level: C, Grade of recommendation: II, Expert consensus: 93.2%)

Question 4. Is reducing the dose of sedatives effective in lowering the incidence of severe AEs associated with endoscopic sedation in older adults?

Background: Although the definition of the elderly is not concrete, the United Nations uses the age of 65 years as the standard to determine an aged society and aging society. Korea became an aged society with a ≥65 years population exceeding 14% of the total population in 2017. In these CPGs, we define an older adult as a person aged ≥65 years. However, we do not strictly distinguish the recommended sedation strategies based on biological age in this guideline because biological age is a continuous variable that can differ between individuals.

Older adult shows an elevated susceptibility to sedatives due to various physiological changes.20 As individual ages, a ventilation-perfusion mismatch can result in reduced arterial oxygen saturation,21 and cardiopulmonary stimulation in response to hypoxia or hypercapnia is delayed or diminished. The incidence of respiratory depression and transient apnea caused by drugs that inhibit the central nervous system also increases with age. The risk of aspiration increases with age due to the need for stronger stimuli to trigger the epiglottis reflex.22 In addition, increasing fat fraction with aging can lead to an increased volume of distribution of lipid-soluble drugs such as benzodiazepines. Diminished hepatic and renal clearance rates result in a longer recovery time. Ultimately, the required dose of general sedatives is reduced due to increased central nervous system sensitivity, changes in drug receptors, changes in the volume of distribution, and inter-compartmental clearance.

However, age alone is not a key factor that increases the risk of sedation-related AEs. Other aging-related morbidities and rapid or excessive drug administration are known to have greater contributions to cardiopulmonary AEs associated with endoscopic sedation.20 One prospective cohort study reported that the age group of ≥80 years had a significantly higher percentage of those with oxygen desaturation than the age group of <80 years after standard moderate sedation for colonoscopy (27% vs 19%, p=0.007). Such oxygen desaturation was found to be associated with the dosage of meperidine (1.05 mg/kg vs 0.75 mg/kg).23

Thus, one of the first precautions to administer endoscopic sedation in older patients is to use a lower initial dose and administer it more slowly with a lower total dose.24-26 ESGE and JGES CPGs for sedation and ASGE CPGs for endoscopy in older patients also mention the need to reduce the dose of sedatives.2,10,24 Dosage calculated simply as milligrams per kilogram of body weight may induce serious respiratory depression and hypotension in older adults. Studies, particularly RCTs, on whether reducing the dose of sedatives can lead to a lower incidence of severe AEs are lacking. However, one prospective observational study reported that the same blood concentration and level of sedation were achieved with less than half of the dose (about 40%) in elderly patients aged ≥90 years compared to those aged <90 years.27 Another prospective observational study also mentioned that the appropriate dose of sedatives for older adults was less than for younger individuals.28 Furthermore, several prospective and retrospective studies–although the age of the study population and type of endoscopy varied–reported that the dose of sedatives needed to achieve a proper level of sedation was lower for older adults compared to that for younger ages and that the use of a higher dose of sedatives was associated with an increased incidence of AEs.26,27,29-32 As for younger ages, midazolam or opioid analgesics are generally used for sedation in older patients. Fentanyl might be more beneficial for older patients because it can promote a rapid recovery due to quick onset of action and short half-life than meperidine.33 While propofol has a narrower scope of safety in older patients, studies have documented that propofol can also be used relatively safely for older patients if it is used under continuous monitoring.27,28,33,34 Evidence for reducing the dose of propofol according to age is lacking. However, one study investigated the propofol dose to maintain serum concentration in a 90-year-old person equivalent to a middle-aged person and found that approximately 40% dose of propofol in a 90-year-old person showed similar serum concentrations.27 Therefore, endoscopic sedation can be performed safely for older adults aged 80 years by reducing the initial dose of a sedative to less than half of the standard dose, using a lower additional dose, administering drugs more slowly, and continuously monitoring the patient.

We suggest that properly trained personnel in addition to the endoscopist monitor sedation during endoscopic sedation to prevent fatal AEs during highly challenging endoscopic procedures or extended procedures. (Evidence level: D, Recommendation grade: III, Expert consensus: 87.5%)

KEY QUESTIONS FOR INTRA-SEDATION AND OXYGEN SUPPLY

Question 5. Is having exclusive sedation monitoring personnel effective in preventing fatal AEs associated with endoscopic sedation?

Background: Personnel who are involved only in sedation, not in endoscopy, during endoscopic sedation are referred to as sedation monitoring personnel. Physicians and nursing staff (registered nurses and nurse aids) can be designated as sedation monitoring personnel.35 Physicians and nursing staff performing endoscopy and sedation monitoring personnel must complete a propofol-based sedation-related training certified by the Korea Medical Association to learn about sedation-related AEs. They must be well aware of appropriate patient monitoring methods, sedation dosing, pharmacodynamics and pharmacokinetics of the drugs involved, drug interactions, potential AEs and management, and airway management methods.3,35

Non-anesthesiologists (i.e., non-anesthesiologist physicians or nurses) administration of propofol (NAAP) is safe and effective in several types of endoscopic procedures that require moderate sedation.36-39 Although high-quality data are lacking, one meta-analysis has shown that NAAP is as safe as the administration of propofol by an anesthesiologist in routine endoscopy for patients with ASA Physical Status classes I-II.40 Routine endoscopy requiring moderate sedation can be performed adequately by one endoscopist, one nurse, and monitoring oxygen saturation.41 As for sedated diagnostic upper gastrointestinal endoscopy in patients with ASA class I-III, sedation by anesthesiologists increases the incidence of sedation-related AEs. Sedation by anesthesiologists does not have safety benefits in colonoscopy.42 It is not cost-effective for screening colonoscopy.43 It can increase the risk of aspiration in colonoscopy44 and elevate the overall risk of AEs.45 Indications for consulting an anesthesiologist include ASA Physical Status class III or higher, challenging airway, severe obstructive pulmonary disease, coronary artery disease, congestive heart failure, and need for deep sedation.2,10,46

Regarding sedation monitoring personnel, the 2010 ESGE CPGs recommended having sedation monitoring personnel during propofol-based sedation.47 However, the revised 2015 ESGE CPGs did not strongly recommend it10 because Swiss, German, and international surveys revealed that many countries performed endoscopic sedation without exclusive sedation monitoring staff, and the incidence of AEs did not increase markedly.7,38,48 This does not mean that sedation monitoring staff is not needed. Instead, a neutral stance was taken, as there were mixed opinions among guideline authors regarding the need for sedation monitoring personnel in NAAP. The 2018 ASGE CPGs recommend that sedation monitoring personnel be provided during deep sedation using propofol.11 The 2020 JGES CPGs recommend that sedation monitoring personnel be provided during challenging endoscopy, although the level of evidence was low.2 In summary, although sedation monitoring personnel appear unnecessary for routine diagnostic esophagogastroduodenoscopy (EGD), colonoscopy, and simple endoscopic procedures requiring moderate sedation, such as polypectomy, due to the low risk of AEs, sedation monitoring personnel would nevertheless help monitor the patient’s state during sedation depending on various factors, such as deep sedation, patient’s state, invasiveness of endoscopy, and proficiency of the endoscopist.35

Consulting and receiving assistance from an anesthesiologist for challenging sedated endoscopic procedures is practically difficult in the Korean healthcare environment, except for a few tertiary healthcare facilities. However, a 2016 Korean survey on endoscopic sedation showed that at least two healthcare staffs in addition to the endoscopist were involved in endoscopic sedation in approximately 68.4% of cases,49 suggesting that it would be easier to implement sedation monitoring personnel in endoscopic sedation in Korea. Therefore, if endoscopic sedation is anticipated to be challenging, such as cases requiring deep sedation, challenging airways (obstructive sleep apnea, short neck, Mallampati grade III or higher, laryngopharyngeal tumor, BMI ≥30 kg/m2), ASA Physical Status class III or higher, extended duration of the procedure, highly invasive endoscopic procedure (endoscopic submucosal dissection, stent placement, endoscopic retrograde cholangiopancreatography [ERCP], endoscopic ultrasound and endoscopic ultrasound-guided procedure, small bowel enteroscopy), and history of sedation-related or anesthesia-related AEs, the implementation of sedation monitoring personnel, would be beneficial in clinical practice despite the lack of strong evidence.

We strongly recommend supplemental oxygen administration before and during endoscopic sedation to prevent severe hypoxia. (Evidence level: A, Grade of recommendation: I, Expert consensus: 81.1%)

Question 6. Is supplemental oxygen administration necessary for patients undergoing endoscopic sedation?

Background: Hypoxia is the most common and problematic AE associated with endoscopic sedation. All selected guidelines (ASGE, ESGE, and JGES CPGs) strongly recommend the administration of oxygen to prevent hypoxia during the procedure.2,10,11,35 Several studies have shown that administration of oxygen can lower the incidence of hypoxia and increase oxygen saturation during the procedure in all age groups, including older adults, during EGD, colonoscopy, ERCP, and endoscopic ultrasound. Therefore, the administration of oxygen is essential to prevent hypoxia at all levels of sedation, including moderate and deep sedation.50-62

Denitrogenation and preoxygenation are important for the prevention of hypoxia. The general method of oxygen administration during endoscopic sedation is to administer oxygen after administering sedatives. However, sedatives produce action within 30 seconds to 1 minute after administration. A delay in oxygen administration may lead to hypoxia. Thus, “preoxygenation,” where oxygen administration begins at 1–2 minutes before the administration of sedatives, might be safer. A normal adult has a functional residual capacity of approximately 2,500 mL, consuming approximately 250 mL of oxygen per minute. If the functional residual capacity includes approximately 500 mL of oxygen indoors, hypoxia will occur at approximately 2 minutes after inadequate ventilation with normal metabolic expenditure. If denitrogenation and preoxygenation are performed to reach 100% SpO2, an individual can theoretically survive for 10 minutes without respiration. Indeed, the calculation varies for obese patients or patients with pulmonary dysfunction. Although nasal administration of oxygen cannot lead to 100% denitrogenation even with preoxygenation, it can delay the onset of hypoxia. Based on some study findings that preoxygenation 1–2 minutes before the procedure can prevent hypoxia in older adults at high risk for hypoxia, preoxygenation can be considered for at-risk group.60

We strongly recommend continuously assessing the level of consciousness, performing pulse oximetry, and performing noninvasive blood pressure monitoring during endoscopic sedation to enable early detection and treatment of sedation-related AEs. (Evidence level: B, Grade of recommendation: I, Expert consensus: 94.0%)

Question 7. Are assessments of the level of consciousness, pulse oximetry, and noninvasive blood pressure monitoring necessary during endoscopic sedation?

Background: Endoscopic sedation may lead to AEs depending on the depth of sedation and sedatives used. AEs might be temporary. They may also progress to severe cardiopulmonary complications. Therefore, respiratory and circulatory monitoring are crucial to prevent them.63 ASGE, ESGE, and JGES CPGs all recommend continuous monitoring of the level of consciousness, oxygen saturation, and blood pressure during endoscopic sedation to detect and treat sedation-related AEs early on.2,10,11

The depth of sedation differs according to the type of sedative, type of endoscopic procedure, difficulty of the procedure, and patient’s status. Sedation dosing should be adjusted by repeatedly assessing the patient’s level of consciousness to determine whether the targeted sedation depth has been achieved (four levels of sedation by ASA) (Table 5).64

Table 5

Level of sedation by American Society of Anesthesiologists

	Minimal sedation(anxiolysis)	Moderate sedation/analgesia(conscious sedation)	Deep sedation/analgesia	General anesthesia
Patient response	Respond normally to verbal commands	Respond purposefully to verbal commands alone or by light tactile stimulation	Respond purposefully to pain and repeated stimulation	No response even to painful stimulation
Airway management	No effect	Additional manipulation unnecessary	May require additional manipulation	Requires frequent manipulation
Spontaneous breathing	No effect	Maintained normally	May be compromised	Mostly impaired
Cardiovascular function	No effect	Generally maintained	Generally maintained	May be impaired

There are a few methods to assess the level of consciousness of patients, including the four levels of sedation proposed by the ASA, modified observer’s assessment of alertness and sedation (MOAA/S) scale (Table 6), and Ramsay Sedation Scale. The four levels of sedation proposed by the ASA are difficult to utilize during the procedure. Therefore, the MOAA/S scale or the Ramsay Sedation Scale can be used for intraprocedural sedation assessment. The accredited endoscopy unit certification system by KSGE uses the MOAA/S scale. The patient’s level of consciousness must be continuously assessed using sedation scales.

Table 6

Modified Observer’s Assessment of the Alertness/Sedation Scale

Score	Responsiveness
5	Alert, and responds readily to name spoken in normal tone
4	Alert, and responds lethargically to name spoken in normal tone
3	Drowsy, and responds only after name is called loudly and/or repeatedly
2	Drowsy, and responds only after mild prodding or shaking
1	Responds only after strong stimulation (painful trapezius squeeze)
0	No response even after strong stimulation (painful trapezius squeeze)

Moderate and deep sedation require periodic assessments of the patient’s level of consciousness and vital signs. It is recommended to monitor them at a minimum of 5-minute intervals before sedation, immediately after administering sedatives, during sedation, during recovery, and before discharge.11,65 For respiratory monitoring, it is important to check breathing status and respiratory rate. Monitoring oxygen saturation through pulse oximetry is recommended for all patients, as it helps prevent AEs by early detection of hypoxia.64,66,67 Circulatory monitoring involves periodically measuring blood pressure using a noninvasive blood pressure monitor. It enables early detection of hypotension.64,68 Pulse oximetry and noninvasive blood pressure monitoring are inexpensive and easy to use. Therefore, they are recommended for use in all patients undergoing endoscopic sedation.2,10,11

Although there are no RCTs assessing the level of consciousness or monitoring oxygen saturation and blood pressure in patients undergoing endoscopic sedation, an European survey has reported that the use of blood pressure and oxygen saturation monitoring has consistently increased over the past decades. Currently, measuring blood pressure and oxygen saturation during sedation is standard practice.38 A Spanish study in 2014 reported that 99.6% and 86.7% of endoscopy units were equipped with a pulse oximeter and blood pressure cuff, respectively.69 A German survey performed in 2010 reported that oxygen saturation was measured using a pulse oximeter in 97% of patients who underwent endoscopic sedation.70 A Korean study in 2016 showed that 94.1% of healthcare facilities measured oxygen saturation using a pulse oximeter (100% in university hospitals and 91.8% in non-university hospitals).49 The safety of endoscopic sedation can be ensured through continuous assessment of the level of consciousness and measurement of oxygen saturation using a pulse oximeter and noninvasive blood pressure monitoring.

We suggest that appropriate criteria should be established to determine a patient’s readiness for discharge to ensure safe recovery and that the level of consciousness, appendicular skeletal muscle activity, respiration, circulation, and oxygen saturation should be considered as criteria for discharge. (Evidence level: D, Grade of recommendation: III, Expert consensus: 91.5%)

KEY QUESTIONS FOR AFTER SEDATION AND PREPARATION FOR DISCHARGE

Question 8. Is the application of appropriate criteria for discharge from the post-endoscopy recovery room effective in preventing AEs after sedation?

Background: After endoscopic sedation, patients should be monitored for abnormal signs.71 After the procedure, it is imperative that properly trained personnel monitor a patient’s cardiopulmonary function in an independent recovery room equipped with appropriate monitoring and resuscitation equipment.15,65 It would be desirable to establish standardized discharge criteria to determine post-sedation recovery. The most common systems used to assess post-endoscopic recovery are the Aldrete scoring system and the modified post-anesthesia discharge scoring system (Table 7). The Aldrete scoring system assesses a patient based on respiration, oxygen saturation, blood pressure, level of consciousness, and appendicular skeletal muscle activity.72,73 Modified post-anesthesia discharge scoring system uses circulation (blood pressure and pulse), mobility, nausea and vomiting, pain, and bleeding at the procedure site as criteria.74,75 These two systems were developed as indicators for post-anesthesia recovery after outpatient surgeries. However, they are currently the most widely used methods to assess recovery after endoscopic sedation. The discharge criteria should be appropriate to the context of each endoscopy recovery room, focusing on ensuring post-sedation recovery and safe discharge.76,77

Table 7

Criteria for Discharge from the Post-Endoscopy Recovery Room

The Aldrete scoring system	The post anesthetic discharge scoring system
Respiration	Vital signs
Able to take deep breath and cough=2	BP& pulse within 20% pre-anesthesia=2
Dyspnea/shallow breathing=1	BP& pulse within 20%–40% pre-anesthesia=1
Apnea=0	BP& pulse within >40% pre-anesthesia=0
O2 saturation	Activity
Maintains >92% on room air=2	Steady gait, no dizziness or meets pre-anesthesia level=2
Needs O2 inhalation to maintain O2 saturation >90%=1	Requires assistance=1
O2 saturation <90% even with supplemental oxygen=0	Unable to ambulate=0
Consciousness	Nausea & vomiting
Fully awake=2	Minimal/treated with p.o. medication=2
Arousable on calling=1	Moderate/treated with parenteral medication=1
Not responding=0	Severe/continuous despite treatment=0
Circulation	Pain
BP±20 mm Hg pre-anesthesia level=2	Controlled with oral analgesics and acceptable to patient:
BP±20–50 mm Hg pre-anesthesia level=1	Yes=2
BP±50 mm Hg pre-anesthesia level=0	No=1
Activity	Surgical bleeding
Able to move 4 extremities=2	Minimal/no dressing changes=2
Able to move 2 extremities=1	Moderate/up to two dressing changes required=1
Able to move 0 extremities=0	Severe/more than three dressing changes required=0

Both of the discharge standards are satisfied if the score is 9 or above.

BP, blood pressure; p.o., per os.

Data supporting recovery time by the type of drug used are lacking. There was no significant difference in the degree of consciousness recovery, quality of consciousness recovery, or time of discharge between the use of propofol and the use of opioid analgesics with midazolam.78,79 The combined use of traditional sedatives and propofol tends to shorten recovery and promote early discharge.80

We recommend that patients who undergo endoscopic sedation be accompanied by a caregiver to assist with safe discharge, as psychomotor and cognitive impairments can occur after sedation. (Evidence level: C, Grade of recommendation: II, Expert consensus: 81.4%)

Question 9. Should patients be accompanied by a caregiver when presenting with endoscopic sedation?

Background: Patients who undergo endoscopic sedation may experience psychomotor and cognitive impairments after the procedure. A prospective study of 31 patients who underwent sedated EGD using midazolam and meperidine reported that the psychomotor functions of the patients were impaired by an average of 30%–40% compared to their pre-sedation state, even though they met the discharge criteria.71 They should be accompanied by a caregiver at discharge, as patients are at risk of experiencing sedation-related AEs after discharge due to impaired psychomotor and cognitive functions. The ESGE guidelines also strongly recommend that patients be accompanied by a caregiver upon discharge after endoscopic sedation. Furthermore, the 2016 clinical recommendations for propofol-based sedation for physicians in Korean healthcare clinics and hospitals recommend that patients who undergo fol-based sedation should be accompanied by a caregiver to ensure safe discharge and availability of a person who can contact the clinic or hospital upon onset of sedation-related AEs after discharge.35 Caregivers include family members, relatives, and friends who can help with safe discharge of the patient after endoscopic sedation. However, there are no established guidelines on whether only family members and relatives who can take responsibility in case of an accident should be eligible caregivers. Therefore, the eligibility of a caregiver should be determined based on the internal policies of each facility.

The degree of psychomotor and cognitive impairment after discharge varies according to the sedatives and combinations of drugs used for endoscopic sedation. In particular, using a drug with a relatively longer duration of action and half-life, such as midazolam and opioid analgesics, can lead to more severe impairment of psychomotor and cognitive functions than propofol alone. A prospective study that performed minimal sedation with midazolam alone in 30 patients undergoing colonoscopy reported that 25 patients showed clear cognitive impairment even 2 hours after the procedure.81 Furthermore, in a prospective study of three combined regimens (midazolam/fentanyl, midazolam/fentanyl/propofol, and midazolam/propofol) in patients undergoing EGD and colonoscopy consecutively, all three groups showed cognitive impairment at discharge, with the dosage of midazolam and fentanyl having a marked effect on cognitive impairment.79 Meanwhile, sedation with propofol alone led to relatively fewer cases of cognitive impairment compared to midazolam alone or a combination of midazolam with another drug. According to one Japanese study, approximately 92% of 400 patients who received low dose propofol-based sedation for EGD safely drove home after discharge.82 A prospective study conducted on patients who underwent colonoscopy with propofol alone sedation also observed that patients’ psychomotor function, driving ability, and blood propofol concentration returned to normal levels within 1 hour after the procedure.83 Similarly, 65% of 2,101 patients who underwent propofol alone sedation for colonoscopy safely drove home themselves.84 An RCT that compared propofol alone, propofol/fentanyl, and midazolam/fentanyl regimens reported that the propofol alone group had minimal cognitive impairments.85 According to a recent RCT on 415 patients who underwent sedated colonoscopy, the propofol alone group (n=205) showed relatively less cognitive impairment at 1 hour after the procedure than the combined midazolam/propofol group (n=210).78 There are details on sedatives for endoscopic sedation in A Guidebook on Endoscopic Sedation 2021 Revised Edition published by KSGE. For more information on sedatives, please refer to this guidebook. Designing RCTs to prove that having patients be accompanied by a caregiver upon discharge after endoscopic sedation can lower the incidence of sedation-related AEs is practically and ethically impossible. However, several studies have reported that patients show psychomotor and cognitive impairments compared to pre-sedation levels, even though the discharge criteria are met. Because this may hinder safe discharge, we recommend that patients should be accompanied by a caregiver at discharge. Midazolam and opioid analgesics with relatively longer durations of action and half-life tend to cause more severe psychomotor and cognitive impairment after sedation. However, sedation with propofol alone may also cause such impairments. Therefore, having a caregiver is essential. In general, family members can serve as caregivers. The specific definition of a caregiver will be addressed in the subsequent update considering the reality in Korea.

CONCLUSION

The use of endoscopic sedation is expected to increase in the coming years due to its benefits, such as alleviating the anxiety of patients, thus boosting their willingness to undergo testing in the future and ensuring a relaxed and comfortable environment for the endoscopist to perform the procedure. International CPGs for endoscopic sedation mostly deal with two aspects of endoscopic sedation: efficiency and safety. However, the details of efficient endoscopic sedation that involve the choice of sedative, dosage, administration, and use of music during sedation can differ across countries. However, this remains controversial. Therefore, we focused on the safety aspect of endoscopic sedation in these CPGs and present the minimal criteria to ensure safe sedation procedures. Further accumulation of clinical evidence in Korea would enable the inclusion of content for efficient endoscopic sedation. Although it was not easy to present consistent criteria due to differences in the type of healthcare facility, region, physician-nurse, and individual experiences, adhering to the safety criteria delineated in these CPGs to prevent severe AEs would allow endoscopists to provide safer sedated endoscopic procedures.

SUPPLEMENTARY MATERIALS

Supplementary materials can be accessed at https://doi.org/10.5009/gnl210530.